Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.3.0.814
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Assets    
Financing receivables $ 736,250 $ 552,706
Financing receivables held-for-sale 41,206 62,275
Investments available-for-sale 28,186 27,273
Real estate 129,344 90,907
Real estate related intangible assets 25,840 23,058
Equity method investments in affiliates 165,280 143,903
Cash and cash equivalents 30,680 58,199
Restricted cash and cash equivalents 14,371 11,943
Other assets 36,408 39,993
Total Assets 1,207,565 1,010,257
Liabilities:    
Accounts payable, accrued expenses and other 16,592 11,408
Deferred funding obligations 78,436 88,288
Credit facility 378,096 315,748
Asset-backed nonrecourse debt (secured by assets of $360 million and $248 million, respectively) 288,300 208,246
Other nonrecourse debt (secured by financing receivables of $101 million and $108 million, respectively) 104,761 112,525
Total Liabilities $ 866,185 $ 736,215
Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 31,221,982 and 26,377,111 shares issued and outstanding, respectively $ 312 $ 264
Additional paid in capital 381,424 293,635
Retained deficit (43,467) (25,006)
Accumulated other comprehensive (loss) income (862) 406
Non-controlling interest 3,973 4,743
Total Equity 341,380 274,042
Total Liabilities and Equity $ 1,207,565 $ 1,010,257